{'fraction_non_alphanumeric': 0.03656307129798903, 'fraction_numerical': 0.010968921389396709, 'mean_word_length': 5.765432098765432, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Myoclonic Encephalopathy Related to SARS‐CoV‐2 Infection

Neurological manifestations have been increasingly recognized as possible complications of SARS-CoV-2 (COVID-19) disease. However, movement disorders were scarcely reported in this context. In particular, myoclonus was initially described in intensive care unit (ICU)-admitted patients, where a multifactorial etiology was commonly found. However, it has been progressively reported as a COVID-19-related feature in a broad range of patients across the entire spectrum of disease severity.